Skip to content

Vaccine call for action: add your voice by June 25

Drug access table: June 2001 update

Global AIDS and Health Fund: what is it?

Direct to consumer drug ads coming soon in Europe?

Treatment interruptions: no addition to viral reservoir seen

Boosted NRTIs may overcome resistance and toxicity

Adefovir for hep B: not an HIV resistance risk

Resistance after nevirapine prophylaxis appears more common in women with HIV subtype D

Transmission of unusual HIV variants may increase risk of treatment failure